Phase I trial, Quotient Sciences code: QSC206403

Phase 1

• Conditions: Healthy volunteers; Not Applicable

• Registration Number: ISRCTN45504491
• Lead Sponsor: Anavex Germany GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-18
• Last Update Posted: 17 April 2023
• Study Completion: 2023-07-27

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Healthy volunteer

Exclusion Criteria

The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Secondary Outcome Measures

Name	Time	Method
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.